Idexx Laboratories

IDXX US Health Care Health Care Equipment
S&P 500 Nasdaq 100
$504.70
-0.36%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.28.
  • Comfortable interest cover: operating profit covers interest about 35 times.
  • Return on equity is healthy at 65.7%.
  • Return on capital employed is healthy at 59.3%.
  • Net profit margin is strong at 24.6%.

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
19.44

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Piotroski F-ScoreStrong
7 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$39.76B
Current Price$ 504.70
High / Low$ 769.98 / 500.61
Stock P/E35.467323
Book Value$ 20.33
Dividend Yield0%
ROCE59.30%
ROE65.70%
Debt to Equity0.28
Current Ratio1.23
P/B Ratio24.685743
EPS$ 13.08
Debt$449.84M
PAT Margin24.62%
Cash PAT$1.20B
ICR35.01
Educational data only. Not a recommendation to buy, sell or hold any security.